The production of deepoxy metabolites of the trichothecene mycotoxins T-2 toxin and diacetoxyscirpenol, including deepoxy HT-2 (DE HT-2), deepoxy T-2 triol, deepoxy T-2 tetraol, deepoxy 15-monoacetoxyscirpenol, and deepoxy scirpentriol is described. The metabolites were prepared by in vitro fermentation with bovine rumen microorganisms under anaerobic conditions and purified by normal and reverse-phase high-pressure liquid chromatography. Capillary gas chromatographic retention times and mass spectra of the derivatized metabolites were obtained. The deepoxy metabolites were significantly less toxic to brine shrimp than were the corresponding epoxy analogs. Polyclonal and monoclonal T-2 antibodies were examined for cross-reactivity to several T-2 metabolites. Both HT-2 and DE HT-2 cross-reacted with mouse immunoglobulin monoclonal antibody 15H6 to a greater extent than did T-2 toxin. Rabbit polyclonal T-2 antibodies displayed greater specificity to T-2 toxin compared with the monoclonal antibody, with relative cross-reactivities of only 17.4, 14.6, and 9.2% for HT-2, DE HT-2, and deepoxy T-2 triol, respectively. Cross-reactivity of both antibodies was weak for T-2 triol, T-2 tetraol, 3'OH T-2, and 3'OH HT-2.
The trichothecene mycotoxins are a group of toxic sesquiterpenoids produced by several genera of fungi and, most notably, species of the genus Fusarium (1) . The basic ring structures of trichothecenes and their corresponding deepoxy analogs are shown in Fig. 1 . T-2 toxin, diacetoxyscirpenol (DAS), nivalenol, and deoxynivalenol (DON, vomitoxin) are four of the more important members of the trichothecene mycotoxins. All four of these trichothecenes have been detected as naturally occurring contaminants of agricultural commodities. Consumption of trichothecenecontaminated feeds by livestock and poultry has been associated with adverse health effects including feed refusal, reduced feed efficiency, reduced weight gains, diarrhea, intestinal irritation, emesis, decreased immune response, and death (1, 9, 12, 17, 18, 25) .
Pharmacokinetic studies have demonstrated that T-2 rapidly disappears from the plasma of animals which were administered T-2 intravascularly, with mean plasma depletion half-lives of 13.8, 17.4, and 5.3 min for swine (2) , cattle (2) , and dogs (22) , respectively. DAS also has a short plasma half-life in animals, with a half-life of 11.6 min in swine and 6.4 min in cattle (7) .
T-2, DAS, and DON are all extensively biotransformed in vivo to a variety of metabolites. Pathways of biotransformation include glucuronide conjugation (8, 10) , ester hydrolysis (8, 22) , oxidation of the C-8 isovaleryl group (8, 31) , and epoxide reduction (4, 10, 21, 29, 30, 32, 33) . Removal of oxygen from the epoxide group of a trichothecene mycotoxin to yield a carbon-carbon double bond was originally reported by Yoshizawa et al. (33) . They found that rats receiving orally administered DON excreted a deepoxy metabolite which the authors labeled DOM-1 (deepoxy deoxynivalenol). Subsequently, deepoxy metabolites have been detected as in vitro biotransformation products of trichothecenes (11, 15, 23, 30) , as (10, 20, 29, 33) . Since the deepoxidation of trichothecene mycotoxins is an important pathway of metabolism in animals, quantities of pure metabolites are needed for toxicological evaluation and for analytical standards. Presently, standards for deepoxy trichothecenes remain limited. C6td et al. (11) previously reported a method for the production of deepoxy deoxynivalenol. Recently, we reported that rumen microflora biotransform T-2 and DAS under anaerobic conditions to give deepoxy products, including deepoxy HT-2 (DE HT-2), deepoxy T-2 triol (DE TRIOL), deepoxy 15- monoacetoxyscirpenol (DE MAS) , and deepoxy scirpentriol (DE SCP) (23) . In the present study, we describe a method for production and purification of the deepoxy metabolites of T-2 and DAS and results of the toxicity and anti-T-2 antibody cross-reactivity studies with the purified products.
MATERIALS AND METHODS
Chemicals. T-2 toxin was prepared in our laboratory from cultures of Fusarium sporotrichioides. DON and DAS were purchased from Myco Lab Co., Chesterfield, Mo. Deepoxy deoxynivalenol was prepared from DON as previously described (11) . HT-2, T-2 triol (TRIOL), T-2 tetraol, 15-monoacetoxyscirpenol (MAS), and scirpentriol (SCP) were prepared by alkaline hydrolysis of T-2 and DAS, respectively (28). 3'OH T-2 and 3'OH HT-2 were prepared by incubating T-2 toxin with S-9 liver fractions (centrifuged [9,000 x g] supernatant fraction of liver homogenate) prepared from rats treated with phenobarbital (16 Preparation of deepoxy tetraol. DE HT-2 (1.0 mg) was hydrolyzed with 0.1 N NaOH in 95% methanol (0.5 ml) for 45 min at room temperature. After removal of the solvent, the mixture was redissolved in chloroform-acetone (1:3, vol/vol) and chromatographed on a 1.0-g column of silica (Analytichem, Harbor City, Calif.) in the same solvent.
Toxicity testing. Brine shrimp toxicity bioassays were performed as described by Bergers et al. (3) .
T-2 antibody cross-reactivity determinations. Rabbit polyclonal antibodies were prepared with T-2 hemisuccinatebovine serum albumin conjugate as described by Chu et al. (5) . Mouse immunoglobulin G monoclonal antibody 15H6 (14) , purified from mouse ascites fluid, was obtained from the U.S. Department of Defense. The specificity of the antibody for the various epoxy and deepoxy T-2 metabolites was determined in competitive binding analyses by varying the concentrations of unlabeled metabolites in the presence of a constant quantity of antiserum to give 50% binding inhibition with tritium-labeled T-2 toxin (5). Tritium-labeled T-2 toxin was synthesized (1 Ci/mM) with the tritium label in the C-3 position by the method of Wallace et al. (26) . Radiochemical purity was >99% as determined by thin-layer chromatography.
Derivatization and GC. The corresponding trimethylsilyl (TMS) derivatives of the metabolites were formed before gas chromatography (GC) analysis by dissolving 25 Alkaline hydrolysis of DE HT-2 yielded a more polar compound which remained near the origin of the silica gel (21, 32) . In the present study, normal phase column chromatography also did not completely separate the deepoxy trichothecenes from their epoxy analogs. Although normal phase HPLC was more efficient in resolving the metabolites, the separation was not adequate to eliminate all epoxy trichothecenes from the deepoxy fractions and additional purification by reverse-phase HPLC was required. Deepoxy trichothecenes eluted later than their epoxy analogs by reverse-phase HPLC. Attempts to use only reverse-phase HPLC for purification were unsuccessful because colored substances contaminated the deepoxy fractions. With the combination of both normal and reverse-phase HPLC, the metabolites DE HT-2, DE TRIOL, deepoxy tetraol, DE MAS, and DE SCP were obtained with purities of -99.5%, as determined by capillary GC of the derivatized products.
Both the TFA and TMS derivatives of the deepoxy trichothecenes eluted earlier than did their epoxy analogs by GC. The TMS derivatives were more stable (16) and were preferred for routine analysis; however, TFA derivatives were utilized for mass spectral analysis because of their greater sensitivity. GC retention times of the epoxy and deepoxy trichothecenes are given in Table 1 .
The mass spectra of compounds 1 through 12 were determined by methane-positive chemical ionization of the TFA and TMS derivatives. The mass spectra of compounds 3, 5, 7, 10, and 12 (TMS ether derivatives) are given in Fig. 2 . In general, the major fragments of the deepoxy trichothecenes were each 16 mass units less than that of the corresponding epoxy congener. The chemical ionization mass spectra of TFA derivatives displayed less fragmentation than did those of the corresponding TMS derivatives. Although the TFA ester derivatives gave greater sensitivity by GC-MS compared with the TMS derivatives, the stability of the TMS ether derivatives was much greater. Degradation was detected within 24 h with the TFA derivatives, whereas TMS derivatives were stable for at least 1 week (data not shown).
As in previous studies (23) , direct deepoxidation products of T-2 or DAS (deepoxy T-2 or deepoxy DAS) were not detected; only their deacylation products were. Because of the relatively slow rate of epoxide reduction observed with this in vitro system, coupled with the more rapid rate of C-4 ester hydrolysis, it is unlikely that direct epoxide reduction occurs with trichothecenes containing a C-4 ester.
The comparative toxicities of T-2, DAS, and their metabolites were established by a brine shrimp bioassay ( Table 2) . The 50% lethal concentration of T-2 in this bioassay system, 111 ng/ml, was similar to the previously reported value of 86 ng/ml by Bergers et al. (3) . The deacylated products of T-2 displayed a general decrease in toxicity corresponding to a loss of esterified side groups. In contrast to T-2 toxin, MAS, the initial C-4 hydrolysis product of DAS, was more toxic to brine shrimp than the parent compound was. The relative toxicities of DAS and MAS apparently are dependent upon the test system employed. DAS is a more potent protein synthesis inhibitor in Vero cells, whereas MAS is more toxic than DAS to mice administered these mycotoxins intraperitoneally or subcutaneously (24) . Although the C-4 hydrolysis product MAS was slightly more toxic than DAS in the brine shrimp bioassay, hydrolysis of all esters to yield the parent alcohol SCP resulted in a significant decrease in toxicity. In all cases, the deepoxy trichothecene analogs displayed little or no toxicity to the brine shrimp under these bioassay conditions. The highest concentration of the deepoxy metabolites examined, 6,000 ng/ml, resulted in the death of less than 50% of the brine shrimp. Reduction of the epoxide group produced at least a 50-fold reduction in toxicity compared with T-2 toxin. Taking into consideration the finding that the deepoxy metabolite preparations were 99.5% pure and the major contaminants were the corresponding epoxy congeners, epoxide reduction may be viewed as a significant single-step detoxification reaction.
To date, little information pertaining to the toxicity of deepoxy trichothecenes has been reported. Yoshizawa et al. (30) found that the acute toxicity of deepoxy 3'OH HT-2 to mice was extremely low compared with its epoxy analog 3'OH HT-2. In the present study, the deepoxy trichothecenes exhibited little or no toxicity to brine shrimp, thus demonstrating that the reduction of the epoxide group in trichothecene mycotoxins by anaerobic microflora is an effective means of detoxification. The role that epoxide reduction plays as a pathway for trichothecene detoxification in situ and possible species variations in toxicity remains to be established.
The binding specificities of two different types of anti-T-2 antibodies were assessed by a competitive radioimmunoassay. The cross-reactivity of compounds 2 through 6 to the antibodies relative to T-2 toxin is given in Table 3 . The results demonstrate that the rabbit polyclonal antibodies were more specific for T-2 toxin than were the mouse monoclonal antibodies. HT In contrast, the monoclonal antibody displayed approximately twice the binding activity to HT-2 and DE HT-2 as it did to T-2 toxin. The greater affinity of the monoclonal antibody 15H6 for HT-2 compared with its affinity for T-2 toxin was previously described (14) ; however, the affinities of anti-T-2 antibodies to deepoxy metabolites have not been reported. Although the data presented support the conclusion that the 12,13-epoxide group is essential for toxicity, the strong cross-reactivity of monoclonal antibodies to DE HT-2 demonstrates that the epoxide moiety is not an essential epitope for antibody recognition. Of additional interest was the observation that the monoclonal antibody displayed limited (10%) cross-reactivity to DE TRIOL but not to TRIOL, its epoxy congener. Recently, Gendloff et al. (13) reported the production of mouse monoclonal T-2 antibodies which displayed strong cross-reactivity to the metabolites bConcentration which caused 50%o lethality to brine shrimp in 24 h at 25°C.
Each value is the mean of duplicate assays.
c Less than 50%o mortality observed at 6,000 ng/ml, the highest concentration examined.
d Less than 20% mortality at 5,000 ng/ml, the highest concentration examined. e Less than 20% mortality at 6,000 ng/ml, the highest concentration examined.
3'OH T-2 (100%, relative to T-2 toxin) and 3'OH HT-2 (20%, relative to T-2 toxin) but only weak cross-reactivity to HT-2 (2%, relative to T-2 toxin).
These data demonstrate that antibodies produced against trichothecenes can vary greatly in their sensitivity and must be evaluated for cross-reactivity with a variety of metabolites, including deepoxy compounds, for accurate results to be obtained. However, in certain circumstances, strong cross-reactivity to trichothecene metabolites may be advantageous. Since deepoxidation and 3'-hydroxylation (with respect to T-2 toxin) are major pathways of biotransformation, antibodies which cross-react with these metabolites would be useful for screening biological fluids.
Recently, antibodies and immunoassay tests have been developed for the analysis of T-2 toxin (5, 13, 14, 19, 27, 34) , DAS (6, 34) , and DON triacetate (35) . Immunoassays should provide rapid and inexpensive means for screening feed or biological fluid samples for trichothecenes. Immunologically based screening assays offer several advantages over chromatographic and spectroscopic methods of analysis including ease of analysis, high sensitivity, decreased cost, and high specificity. However, immunoassays are screening techniques requiring confirmation of positive samples, generally accomplished by GC or GC-MS techniques. Since bRelative binding cross-reactivity of trichothecene metabolites to the antibodies compared with T-2 toxin (nanograms of T-2 required to displace tritium-labeled T-2 by 50%o/nanograms of metabolite required to displace tritium-labeled T-2 by 50%) x 100.
c Rabbit polyclonal T-2 antibodies. d Mice monoclonal T-2 antibody strain 15H6. both HT-2 and DE HT-2 strongly cross-react with mouse monoclonal antibody to T-2 toxin, confirmation of positive immunoassay samples by GC-MS must take into account not only T-2, but also metabolites of T-2. The present report describes a method for production of deepoxy trichothecene standards which are essential for confirmation of trichothecene exposure.
